BOT vs DXB

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

BOT

BOTANIX FPO [BOT]

37LOW

DXB

DIMERIX FPO [DXB]

37LOW

Score Breakdown

BOT DXB
Technical
62
51
Catalyst
63
58
Sentiment
50
50
Fundamental
56
82
Momentum
29
39
Risk Gate
40
50

Key Metrics

BOT Metric DXB
$93.2MMarket Cap$198.1M
16.0MAvg Volume (20d)1.2M
+1.3%Short Interest+0.1%
$0.48552-Week High$0.785
$0.03952-Week Low$0.310
+0.0%Daily Change+1.6%
$0.040Entry Price$0.325
-121.1%ROE-594.5%
N/AProfit Margin-219.9%

Active Signals

BOT Signals

RSI is looking oversold — historically a spot where stocks tend to bounce
MACD momentum is picking up steam
Stochastic is deep in oversold territory — bounce conditions forming
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Trading below both moving averages — the trend is working against this one
Above-average volume (1.9x) on a green day — buyers stepping up
Sitting near support — this level has held before and could attract buyers again
Took a hit — down 11.1% over the last 5 days

DXB Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Strong revenue growth (+636%)
EPS estimates revised upward (+10pts)
Near 52-week low (4% of range)

Ask Scout AI to compare BOT and DXB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
BOT Full Analysis → DXB Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).